Bionomics Limited, based in Australia, is a company that focuses on the research and development of therapeutics for cancer and diseases of the central nervous system. Their portfolio includes programs in small molecule product development for anxiety, epilepsy, multiple sclerosis, and cancer treatment. The company is dedicated to discovering new therapies that can improve patients' lives and is a promising player in the biotech industry.